https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-01 / J. Immunother. 2015 May;38(4):155-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-01 / J. Immunother. 2015 May;38(4):155-642015-05-01 00:00:002019-02-15 08:45:07Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-882015-05-01 00:00:002015-05-01 00:00:00Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-23 / Swiss Med Wkly 2015;145:w14133
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-23 / Swiss Med Wkly 2015;145:w141332015-04-23 00:00:002015-04-23 00:00:00Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-18 / Breast 2015 Aug;24(4):418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-18 / Breast 2015 Aug;24(4):418-252015-04-18 00:00:002015-04-18 00:00:00Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-17 / Eur. J. Immunol. 2015 Jun;45(6):1783-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-17 / Eur. J. Immunol. 2015 Jun;45(6):1783-932015-04-17 00:00:002019-02-15 08:45:04Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-16 / Tumour Biol. 2015 Sep;36(9):7121-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-16 / Tumour Biol. 2015 Sep;36(9):7121-312015-04-16 00:00:002019-02-15 09:22:44Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-14 / Chonnam Med J 2015 Apr;51(1):1-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-14 / Chonnam Med J 2015 Apr;51(1):1-72015-04-14 00:00:002019-02-15 08:51:23Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-12 / Cancer Immunol. Immunother. 2015 Jul;64(7):831-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-12 / Cancer Immunol. Immunother. 2015 Jul;64(7):831-422015-04-12 00:00:002019-02-15 08:45:10Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-09 / Cell 2015 Apr;161(2):205-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-09 / Cell 2015 Apr;161(2):205-142015-04-09 00:00:002019-02-15 08:35:55Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-07 / PLoS ONE 2015;10(4):e0120228
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-07 / PLoS ONE 2015;10(4):e01202282015-04-07 00:00:002015-04-07 00:00:00High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial
